findmyKOL

Jacob Korula, MD

Basic profile

Good Samaritan Hospital

ORCIDNone on fileNPI
RegionArcadia, CA · WestSpecialtyGastroenterologyFocusGastroenterology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2011Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Jacob Korula is a Gastroenterology physician affiliated with Good Samaritan Hospital. OpenAlex indexes 103 publications with 2,359 citations (h-index 20).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
103publications

Distinct works indexed by OpenAlex.

2,359citations

Total citations across indexed works.

20h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
14companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

622 W Duarte Rd
Suite 302
Arcadia, CA 910079278

Telephone

626-447-5339

Registry record last updated 5 Jan 2009.

View the NPPES registry record

Industry payments

14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    59.1%
    Proton pump inhibitor26.8%
    Pantoprazole Sodium53%Omeprazole24%Esomeprazole Magnesium13%Dexlansoprazole Dr11%
    Part D<11 patients
    Bile Acid12.9%
    Ursodiol100%
    Part D<11 patients

    + 5 more classes in this area

  • Anti-infectives

    17.6%
    Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor9.2%
    Lamivudine Hbv51%Entecavir49%
    Part D<11 patients
    Nucleoside and nucleotide reverse transcriptase inhibitors8.4%
    Vemlidy100%
    Part D<11 patients
  • Cardiovascular

    13.6%
    Loop diuretic7.9%
    Furosemide100%
    Part D<11 patients
    Aldosterone antagonist (MRA)5.8%
    Spironolactone100%
    Part D<11 patients
Where care is delivered (Part B)54.7% facility · 45.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”